U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

LEPIDIUM MEYENII WHOLE

MORE DETAILS

94866V8426

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Debaosheng by Shenzhen Deyintang Biotechnology Co., Ltd.
(2022)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d892f790-efb6-27ad-e053-2a95a90af470
First approved in 2014
Source:
Singiso by FDA TRADING CO.,LTD.
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c19a75c-e68a-49f1-be3d-24e0b47183bf
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966